Autolus Therapeutics (AUTL) Cash from Investing Activities (QoQ) (2018 - 2025)
Autolus Therapeutics (AUTL) Cash from Investing Activities (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Autolus Therapeutics | 393.78 Mn | 93.07 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 143.46% |
| Sep 30, 2025 | -62.94% |
| Jun 30, 2025 | 261.07% |
| Mar 31, 2025 | 84.48% |
| Dec 31, 2024 | -3,900.30% |
| Sep 30, 2024 | -1,040.19% |
| Jun 30, 2024 | -57.79% |
| Mar 31, 2024 | 63.91% |
| Dec 31, 2023 | 1.40% |
| Sep 30, 2023 | 65.87% |
| Jun 30, 2023 | -21.18% |
| Mar 31, 2023 | -472.20% |
| Dec 31, 2022 | 90.69% |
| Sep 30, 2022 | -157.46% |
| Jun 30, 2022 | -242.41% |
| Mar 31, 2022 | 51.36% |
| Dec 31, 2021 | 58.95% |
| Sep 30, 2021 | -155.53% |
| Jun 30, 2021 | 20.47% |
| Mar 31, 2021 | 65.28% |